Nellcor buy causes Mallinckrodt loss

Article

One-time charges related to its acquisition of Nellcor Puritan Bennett contributed to a $291.9 million net loss for St. Louis-based Mallinckrodt. The company also reported that earnings in its medical imaging business declined as a result of falling

One-time charges related to its acquisition of Nellcor Puritan Bennett contributed to a $291.9 million net loss for St. Louis-based Mallinckrodt. The company also reported that earnings in its medical imaging business declined as a result of falling prices for contrast media.

For the year, Mallinckrodt reported sales of $2.37 billion, up sharply from $1.7 billion the year before, due to the acquisition of revenues from the Nellcor business. Earnings from continuing operations, not including charges related to the Nellcor purchase, were $132.9 million. Mallinckrodt posted a net profit of $190.1 million the prior year.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.